Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
27
×
Tags
biotech
27
×
life sciences
national blog main
san francisco blog main
boston blog main
national top stories
new york blog main
startups
boston top stories
san francisco top stories
new york top stories
san diego blog main
san diego top stories
fda
boulder/denver blog main
clinical trials
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
raleigh-durham blog main
raleigh-durham top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
cancer
deals
drugs
medical device
boston
eli lilly
takeda pharmaceutical
venture capital
amgen
drug prices
What
drugs
27
×
new
medicines
bio
biotech
drug
fda
proteins
roundup
startup
therapies
advance
aims
biologics
cancer
company
develop
developing
diseases
health
house
life
medications
neuro
plan
research
that’s
therapeutics
unveiled
way
year
approach
available
awaited
biological
biology
called
can’t
cells
ceo
Language
unset
unknown
Current search:
drugs
×
photo
×
biotech
×
@techinasia.com
9 months ago
In 50 Words: Rakuten founder prioritizes US cancer startup amid business losses
@extremetech.com
1 year ago
AI Helps Biotech Labs Generate the Building Blocks for New Drugs
@techcrunch.com
3 years ago
‘It’s almost like placing an IV’: Brain monitoring electrode receives FDA 510(k) clearance
@xconomy.com
3 years ago
Praxis Precision Medicines Leads Way as Three More Biotechs Prep IPOs
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
EnClear Therapies Nets $10M to Test Neuro Disease ‘Dialysis’ Device
@xconomy.com
4 years ago
Decibel Therapeutics Strikes a Balance, Adding Regenerative Med Focus
@xconomy.com
4 years ago
DTx Pharma Raises $10.6M to Advance New Way to Deliver RNA Drugs
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
4 years ago
Pelosi, Dems Unveil Price Plan: Are 25 Drugs Enough for Negotiation?
@xconomy.com
4 years ago
New PCSK9 Cholesterol Drug Faces Tough Foe. (Hint: Not Cholesterol.)
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
4 years ago
White House Floats Canadian Import Plan But Excludes Many Costly Drugs
@techcrunch.com
4 years ago
Neurobehavioral health company Blackthorn pulls in $76 million from GV to treat mental disorders
@xconomy.com
5 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Rani’s “Robotic Pill” for Biologics Clears First Hurdle in Humans
@xconomy.com
5 years ago
Rani’s “Robotic Pill” for Biologics Clears First Hurdle in Humans
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More
@xconomy.com
5 years ago
Synthorx Files for IPO to Advance Enhanced Cytokine Drugs
@techcrunch.com
5 years ago
HP is ‘printing’ drugs for the CDC to speed up antibiotic testing
@xconomy.com
5 years ago
Verana Health Lands $30M Financing Led By GV, Adds Miki Kapoor as CEO
@xconomy.com
6 years ago
Trump Pledges Lower Drug Prices, But Blueprint Is Short on Details
@xconomy.com
6 years ago
Synthorx Raises $63M to Advance Suite of Enhanced Cytokine Drugs
@techcrunch.com
6 years ago
Life sciences startup Avro aims to deliver drugs to children and the elderly through skin patches
@venturebeat.com
7 years ago
Google’s Calico partners with new biotech firm to develop anti-aging and cancer drugs